Final Exam Flashcards
Explain the history behind drug use and development
Drugs have been used since before recorded history as shown evidenced by early written records from China and Egypt which provide a glimpse into agent traditions of drug use.
Ancient Civilizations: healers existed historically in all traditions and cultures of ancient times.
- Greece: Theophrastus wrote a textbook on the therapeutics that included opium, obtained from the opium poppy (palaver somniferum). Serturner, A pharmacist in Germany, isolated crystals of morphine from opium and tested the pure substance on himself and three companions to discover its pain relieving capabilities. Opium contains two important substances which are 10% morphine and 0.5% codeine. The name morphine comes from Morpheus, god of dreams. It can relieve pain a very great intensity. Coding is also widely used for pain relief and does it constitute of Tylenol-3.
- Egypt: Egyptian history was recorded on papyri. One of these papyri, the Ebers Papyrus, why is a textbook of drug use for medical students containing many true observations, particularly on purgatives, which are drugs used to cause bowel movements. One of the drugs recommended was senna which is still used today.
- China: Shen Nung classified all drugs according to taste. For example, Ma Huang was classified as a medium drug widely used for coughs and influenza. And the modern error, ephedrine has been isolated from Ma Huang to treat asthma and produce a derivative for decongestion.
Poisons: The use of poisons has resulted in the discovery of drugs still used today. All substances are poisons, there’s none which is not a poison, the right dose differentiates a poison and a remedy.
- Curare: A plant-derived drug that was historically used by indigenous people in various regions of the Amazon rainforest. As a poison, arrows were dipped in curare to use as a poison for hunting as it acted upon voluntary muscles causing paralysis and eventually death by respiratory paralysis. As a drug it was used by anaesthetists during surgery for muscle relaxation. Newer derivatives are still used by anesthetists today
- Ergot: A poisonous fungus that grows on the heads of rye, particularly during wet seasons. In the middle ages, ergot was ground together with rye, finding its way into bread. This resulted in terrible epidemics that killed over 20,000 people in one region of Russia. As a poison, ergot targets the nervous system resulting in symptoms of mental frenzy, hallucinations, and convulsions. It affects the cardiovascular system by causing constriction of the blood vessels that lead to the fingers, toes, and limbs. In the reproductive system, it causes violent contractions of the uterus. In the early 16th century, midwives used this to hasten labor. However, if not used appropriately it can result in death. As a drug, the ergotamine derivative is useful in treating migraines by preventing the pulsation of blood vessels. Ergonovine was used to Hazenbirth, but now is used to arrest uterine bleeding after childbirth.
Religion: in ancient societies, traditional healers acted as both physicians and priests, resulting in therapy being heavily influenced by religion and magic. In most parts of the world, plants containing intoxicating substances were used by traditional healers to alter the state of consciousness and facilitate communication with their gods. An example of this is peyote from the peyote cactus which was widely used to achieve a mystical state linked to spiritual and realistic use. It contains a potent substance, mescaline, which causes hallucinations, a feeling of well-being, and distortion similar to LSD.
What are drugs? What are the two major categories of drugs?
A drug is any substance received by a biological system that is not received for nutritive purposes, and which influences the biological function of the organism, meaning that chemicals, biological agents, and herbal products are all considered drugs.
About 25% of drugs used today are derived from plant sources where the active substances are purified and potentially modified to be either more effective or less toxic.
Drugs acting on the brain: Drugs that act on the brain alter the normal chemical signalling in the brain.
-LSD: Albert Hoffman tried to synthesize improved pharmaceutical products based on components of ergot but instead synthesized LSD, similar in chemical structure. The discovery of the psychedelic effects of LSD supported the idea that mental illnesses might be due to the production of potent substances in the brain that could produce psychic disturbance. This research stopped in the 1970s and the drug was classified as a controlled substance. Recently, however, evidence indicates that derivatives of LSD might be effective in treating depression, anxiety, and addiction.
Drugs acting against infectious disease: an infectious disease is any disease caused by an organism such as bacteria, viruses, fungi, or parasites.
1900: Organoarsenicals - arsenic and organic molecules can be selectively bound to parasites. This idea was applied to infectious disease to cure syphilis.
1930: Silva Drugs - Synthetic drugs for the treatment of bacterial disease as anti-bacterial compounds.
1940: Penicillin - During the second world war, penicillin was used in therapy of gram-positive bacterial disease.
1950: Streptomycin - antibiotic for tuberculosis and gram-negative bacterial diseases.
What is the process to drug development?
1) Drug discovery: Basic drug research is done through identification of the target, where a target for a new potential drug such as a receptor is found and it’s binding compound is identified and studied to determine pharmacological effects at the molecular, cellular, organ, and animal level; and studying the target, where the binding compound shows promise as a lead compound and enters detailed studies for safety and efficacy.
2) Pre-clinical studies: after the target has been discovered and studied, drugs enter pre-clinical studies which are conducted prior to testing in humans in range from molecular to tissue and animal studies. Pre-clinical studies can be pharmacology studies, which determine the detailed mechanism of action of the new drug, or toxicology studies, which determine the potential risks or harmful effects of the drug. These studies look at acute toxicity, chronic toxicity, and effects of reproductive, carcinogenic, and mutagenic potential.
If a manufacturer wants to test a new drug on humans, three steps are required before they can proceed. This includes proof of safety and efficacy, which must be submitted, from several animal species, to the government regulatory agency in the particular country concerned (Canada - Health products and food branch, USA - FDA), methodology, where the methods of the proposed clinical trial of humans is required, and investigation, where the submission is evaluated by qualified scientists that can give permission to highly qualified investigators like clinical pharmacologists to begin investigation of the drug in humans.
3) Phase 1 clinical trial: carefully evaluate the absorption, distribution, illumination, and adverse effects of the new drug. These trials test one or two doses of the drug to determine the tolerability on a limited number of healthy volunteers (20 - 80). The efficacy of the drug is not assessed.
4) Phase 2 clinical trial: determination of whether the drug is effective in treating the condition for which it is recommended in a limited number of patients with the disease (100 - 500). They also pay careful attention to the safety of the drug.
5) Phase 3 clinical trial: often called a randomized controlled trial‘s (RCT), are the main studies for licensing and marketing of the drug. These studies determine how safe and effective the drug is compared to no treatment or the current recommended therapy. It is tested on a larger number of people to obtain information about the drug in a diverse population. They are also conducted at centres in many cities, as one centre usually does not have the required number or diversity of patients. These trials are the most expensive part of drug development costing upwards of 50 million dollars.
6) Health Canada’s Review: the manufacture will submit to the regulatory body a new drug application containing detailed results of clinical trials. The results are again reviewed by regulatory scientists and, if deemed effective and the toxicity is acceptable, it will be granted approval.
7) Manufacturing: Manufacturers come up with a drug name and a brand name for the drug because chemical names are too complex for general use. Generic names are given to drugs that show promise. Around the same time that that is done, the manufacturer will apply for a patent with a brand name for the drug giving the company exclusive rights to market the drug for 20 years. That 20 year life begins when the patent is filed during pre-clinical development phase, so the effective patent life is in the range of 10 to 12 years. After a patent on a drug expires, other manufacturers can make copies of the original brand-name drug and sell it under their own brand name. The original brand-name drug and any generic versions will all contain the identical active ingredient gradient in the same amount and dosage form. These regulations are in place to ensure that all market of drugs are as effective as the original brand-name drug and or bioequivalent which is achieved by studying comparative bioavailability between blood levels after administration of the original and new brand-name drugs to healthy volunteers under controlled conditions.
8) Post market surveillance (Phase 4 clinical trial): The dragon is carefully watched even after being put on the market. If unexpected changes are seen in patients, there are changes to the drug labels to add warnings or advice about how to take the drug.
What is the design of phase 3 clinical trials?
Please three clinical trials can be divided into three large stages:
1) Enrollment: the people the new drug is tested on have to carefully be defined. The target population is the group of patients for whom the drug is intended. The study population is a subset of the target population that meets all required criteria. Two factors influence who can be included in the study population. This includes inclusion/exclusion criteria, which find characteristics of the patients to be included in the study to determine who is eligible for the trial in order to illuminate variables other than the drug under study that may influence results well also representing the target population. Severity of disease is important to consider and other present diseases as well. However, comorbidities are often included to be representative of the target population. Consent is the other criteria. Before a person can participate, informed consent must be obtained where the patient signs a document written in non-scientific language that outlines the purpose, procedures, and all potential risks and benefits that may occur. These consent documents are reviewed by an independent institutional ethics review board and at any time, or participant can revoke their consent.
2) Treatment: Studies are conducted in a double blind manner where neither the investigator nor the study subject is aware of the treatment the subject is assigned to. This is done to avoid any bias that could occur if the subject believes the drug will work or if the investigator is expecting positive results. Patients recruited for study are assigned to experimental treatment groups or a control group. To ensure these groups are similar, patients are assigned by randomization which ensures that confounding variables are distributed equally between experimental and control groups, removing potential bias. The efficacy and safety of the experimental drug has to be compared to a controlled drug which can either be placebo or a gold standard drug. A placebo does not contain any active drug but has identical in appearance, color, taste, and administration. Placebos can be very efficient in sick and anxious patients. A gold standard drug is a drug acceptable by the medical community has the best available treatment for that disease at that time. If a gold standard drug is a variable, that is what the control group receives so that all patients are receiving some sort of treatment.
3) Results: to determine if the experimental treatment was more or less effective than the control, and outcome of the trial which measures how much the drug worked in each participant is measured and compared in a reliable and objective manner. Factors which can influence the interpretation of a clinical trial must be considered when analyzing results. These include compliance, where patient compliance is tested by having participants bring back orally administered drugs or checking that the nurse signed off on intravenous drugs, quality of life, where the impact on patient quality of life is assessed, and statistics, where the measured outcome is compared to the measured outcome for the control drug using statistics to determine whether the difference is real or by chance.
What are drug targets?
Drugs are designed to interact with a selected target in the body which is commonly a receptor, but there can be other targets in the body.
Receptors: A molecule or complex of molecules on the outside or inside of a cell that has a regulatory or functional role in the organism. Many copies of the same receptor exist on or within a single cell, and many of the same cell types exist in an organ that all work together. This means thousands of the same receptors are within an organism. Receptors are normally bound to an activated by endogenous ligands, which are substances found in the body such as hormones and neurotransmitters. The location of receptors determines where a drug will act and whether the response that results is beneficial or detrimental.
Chemical Reactions: Commonly used antacids neutralize stomach acid through a simple acid-base neutralization reaction.
Physical Chemical Forces: Cholestyramine works by chemically binding the bile acids in the gastrointestinal tract to prevent reabsorption and increase the elimination of bile salts that are used to make cholesterol.
Most drags mimic or block the effect of a ligand at a receptor to stimulate the receptor as an agonist, or block the response as an antagonist.
How is drug response considered?
The intensity of the pharmacological effects produced by a drug increases in proportion to the dose. This is called the dose response relationship, reduce is defined as the amount of drag taken. To compare the effects of two different drugs you must consider the quantity, frequency of use, user demographics, and environmental factors.
For a drug to achieve its desired response, many receptors need to be activated at once. At low doses, very little response is observed as not many receptors are activated. The dose of the drug increases more receptors are activated until the desired response is seen. This is where a threshold exists. Once the threshold is reached a small increase in does result in a large increase in response. The response will increase until reaching a maximal effect where increasing the amount of drug will have no increase in therapeutic response. These can be seen on a dose response-curve.
Define efficacy and potency
Efficacy: the maximum pharmacological response that can be produced by a specific drug in that biological system.
Potency: the dose of drug required to produce a response of a certain magnitude, usually 50% of the maximum response for that drug.
What is therapeutic range?
Therapeutic range is the range of doses that achieve the therapeutic effect by keeping the blood concentration above the minimum which produces the desired response, but below the concentration that produces a toxic response.
What must happen for a drug to reach its desired effect?
To produce its desired effect, a drug must reach the cellular site of action at the right concentration, exert it’s a fact, and then be removed from the body.
Define pharmacokinetics
Pharmacokinetics is a term that refers to the movement of a drug into, through, and out of the body.
What are the different routes of administration?
Topical: drugs are applied directly to a particular place on or in the body by administration on the skin, through the skin, or through inhalation. Drugs applied to the skin treat mild to moderate severity conditions such as eczema, acne, and infection. These drugs, applied for a local affect, can be absorbed and produce a systemic affect. Transdermal drug delivery is the application of a drug to the skin for absorption into the general circulation for a systemic effect. This method of delivery is convenient, delivers a steady drug supply for several days, and bypasses the enzymes of the stomach, intestine, or liver. Drugs administered by inhalation can be rapidly absorbed from the lungs for local and systemic effect. An advantage of inhalation is that the quantities of drugs are smaller than that required for a systemic effect, thus avoiding toxicity associated with oral administration. A disadvantage is that the method requires proper use by the patient.
Enteral: administration via the gastrointestinal tract either through the mouth or an artificial opening. This administration enters the blood through the gastrointestinal tract then is delivered to the liver where enzymes decrease the amount of active drug left to enter the general circulation. This is called the first pass effect. These can be administered by mouth which is commonly used, most convenient, least expensive, and non-invasive, but absorption is variable due to differences in intestinal motility and disease. They can also be administered into the rectum for a systematic or local effect in patients who are nauseated or vomiting. An advantage is that the digestive enzymes of the stomach are bypassed but a disadvantage is that there is only a limited number of medication available for rectal administration and absorption from the rectum mucosa is slow, incomplete, and variable. Sublingual and buccal administration bypasses enzymes of the stomach, intestines, and liver but not all drugs are adequately absorbed this way and if the drug is swallowed, it just behaves as if it were taken orally.
Parenteral: administration bypassing the gastrointestinal tract through intervenous, intramuscular injection, or subcutaneous injection. In intravenous administration, the drug is placed directly into the blood and has immediate effects for drugs that are poorly absorbed, provided that they can be made into a solution in purified water. It must also be considered that the response is irreversible and administration require significant human resources and sterility. In intramuscular administration, the drug is injected deep into a muscle where the volume of drug is limited to 2 to 3 mL in an adult. In subcutaneous administration, the drug is injected into the deepest layer of the skin allowing for the modification of drug preparation to control the timing of release of that drug from the injection site.
Why is there not always a good relationship between the dose of drug and the concentration of drug in the blood?
During absorption, not all of the drug ends up in the blood. This is because bioavailability differs between drugs.
Define bioavailability
Bio availability is defined as the fraction of an administered dose that reaches the systemic circulation in an active form.
What are the four processes involved in pharmacokinetics?
1) absorption: The movement of a drug from the site of administration into the blood. For a drug to be absorbed and distributed two sites of action, it must be able to cross biological membranes. This can be done by diffusion through aqueous pores across a concentration gradient, diffusion through lipids dissolving into the lipid membrane and passing down a concentration gradient, or active/carrier mediated transport where carrier membrane complexes grasp the molecule move through the membrane and release the molecule on the other side.
2) distribution: The movement of a drug from the blood to the side of action and other tissues. Most drugs reach all tissues and organs regardless of the target site of action. The concentration of a drug at the site of distribution is an equilibrium with its concentration in the blood. The rate at which drugs distribute in and out of a particular organ depend on the blood flow to that organ. After administration, drug distribution to the target site allows a response to occur. However, once the concentration begins to reach equilibrium, moving into other tissues and organs, the concentration at the active site begins to decrees and the effect of the drug has been terminated.
3) metabolism: also known as bio transformation, the conversion of a drug to a different chemical compound in order to eliminate it. The products of metabolism are called metabolites which are usually devoid of pharmacological action. To be eliminated from the body by the kidneys, a drug must be water soluble so most drugs are converted to more water soluble compounds. The liver is where most biotransformation reactions occur, but some metabolism occurs in the kidneys, intestines, lungs, skin, and most other organs.
- Phase 1: functional groups are added or unmasked on the drug to prepare it for the addition of a large water soluble molecule.
-Phase 2: Add a large water soluble moiety, usually glucuronic acid or sulfate, making the metabolite water soluble for excretion by the kidney.
4) excretion: includes moving the drug and it’s metabolites out of the body through all bodily fluids.
-kidney: The majority of drugs are eliminated by the kidney. Drugs of sufficient water solubility will be excreted in the urine while lipid soluble drugs can be reabsorbed back in blood.
-G.I. tract: Some drugs are excreted in faeces after undergoing biotransformation in the liver.
-lungs: Volatile or gaseous drugs can be excreted by the lungs.
-breast milk: Drugs are often found in the breastmilk of nursing parents which can expose nursing infants to a therapeutic or toxic dose of the drug.
-saliva and sweat: drugs can be found in saliva and sweat, often in the presence of drug misuse.
What is P450?
P450s are enzymes capable of biotransforming drugs. They are in most tissues, but are present in high concentrations in the liver. The cytochrome P450 family of enzymes biotransforms the vast majority of clinically used drugs.
Why is there variation of drug response?
As drugs undergo five events after administration including absorption, distribution, target interaction, metabolism, and excretion, there are many possible influences at any stage which can contribute to variability in the observed response among patients. Some examples include genetic factors, environmental factors, disease states, physiological states, and the presence of other drugs.
Genetic: variability exists in the receptors to which the drug binds and in the manner in which the body handles and eliminates drugs. The activity of enzymes involved in bio transformation can vary between individuals due to genes that encode for those enzymes. Some individuals are slow biotransformers and others are fast biotransformers.
Environmental: exposure to certain chemicals can increase enzymes in the liver responsible for biotransformation of drugs. This makes these people illuminate the drug more rapidly.
Other disease states: the presence of a disease state may alter the manner in which drugs are handled by the body.
Altered physiological states: as we age, we lose the reserve or redundancy in Nuro function and drugs have a greater affect than expected. Liver and kidney function also decrease with age reducing the rate at which elderly eliminate drugs. Another example is during pregnancy due to increased blood volume, cardiac output, and rate of renal excretion.
Other drugs present: when multiple drugs are taken together it is possible for one drug to change the biological effect of a second, leading to variability in drug response.
What are the adverse effects of drugs?
An adverse drug reaction is defined as any effect produced by a drug in a patient that is not the intended effect.
Extension of therapeutic effect: occurs when there is too much of the drug in the blood (overdose).
Unrelated to main drag action: drugs can cause effects that are unrelated to the intended action like causing nausea. These may or may not be expected.
Allergic reaction: this is mediated by the immune system from an antigen-antibody combination which provokes an adverse reaction in the patient. These can be very mild or very severe.
Withdrawal an addiction: unwanted physiological and psychological effects of the drug can occur.
Teratogenesis: when a drug produces defects in a developing fetus.
Adverse biotransformation reaction: occurs when a drug is converted to a chemically reactive metabolite that combine to tissue components and cause tissue or organ damage.
Why is it difficult to predict adverse drug reactions?
Rarity of occurrence: the toxic reaction may be rare, making it difficult to predict the adverse drug reaction.
Length of usage: toxic reaction my only appear after prolonged use.
Detect ability and animals: the toxic effect may not be detectible in animals and only appear once the drug is being tested in humans.
Time period specificity: the toxic affect maybe unique to a particular period in time.
What is the therapeutic index?
Therapeutic index tells you how safe the drug is relating the dose of the drag required to produce a beneficial effect to the dose required to produce an undesirable or adverse effect. The higher the therapeutic index the safer the drug. When a drug has a low therapeutic index, it is more likely that toxicities will be observed. It is calculated by dividing toxic dose 50 by effective dose 50.
What is toxic dose 50? What is effective dose 50?
TD50: dose of drug that is toxic in 50% of the population.
ED50: dose of drug that is effective in 50% of the population.
Discuss drug-drug interactions
A drug to drug interaction occurs when one drug changes the pharmacological effect of a second. These can occur at many points during the drugs journey through the body.
Absorption: add drag can increase intestinal movement, speeding the passage of a second drug through the intestine and decreasing contact of the second drug with the intestinal wall, thereby decreasing absorption.
Metabolism: a drug can block the inactivation of a second drug in the liver, increasing the blood level and pharmacological effect of the second drug.
Excretion: a drug can facilitate the expression of a second drug by the kidney, decreasing the blood level and pharmacological effect of the second drug.
Discuss drug-food interactions
Drag the food interactions involves interference of food with drugs taken concurrently.
Tyramine: found in well matured cheeses and a variety of other foods. It is capable of raising blood pressure and is broken in the liver by an enzyme known as MAO. One class of anti-depressant drugs are inhibitors of MAO, preventing tyramine from being broken down to inactive products. This causes the blood pressure raising effects of tyramine to be greatly intensified.
Grapefruit: alter the absorption of drugs by inhibiting enzymes that bio transform drugs, resulting in a greater amount of the active drug being absorbed. The higher blood levels of the drug can potentially lead to overdose.
What is the cerebral cortex?
The cerebral cortex, also known as the cerebrum, is the largest part of the brain and is very rich in neurons. The overall functions of the cerebral cortex are: sensory and motor coordination, mental processes, intelligence, memory, vision, judgment, thought, speech, emotions, and consciousness. The neurons in the cerebral cortex can be stimulated or depressed by drugs.
What is the limbic system?
The limbic system is a region of the brain that integrates memory, emotion, and reward. This area of the brain, together with the hypothalamus, controls emotion and behavior. The limbic system contains the dopaminergic reward centers, which are targets for commonly misused drugs and are associated with addiction.